Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic non-GAAP Operating Profit ($M) ($M)
Medtronic Form 8-K GAAP-to-Non-GAAP Reconciliations
Latest, FY2026
8,856
Period ended Apr 30, 2026
Change on a year earlier
+2.4%
8,648 in FY2025
History
11 years
Since FY2016
Sources
10
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Operating Profit ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 8,856 | +2.4% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 8,648 | +4.5% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2024 | Apr 30, 2024 | 8,272 | -0.3% | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2023 | Apr 30, 2023 | 8,295 | -6.3% | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2022 | Apr 30, 2022 | 8,856 | +23.9% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2021 | Apr 30, 2021 | 7,146 | -5.5% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2020 | Apr 30, 2020 | 7,565 | -14.7% | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2019 | Apr 30, 2019 | 8,872 | +6.6% | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2018 | Apr 30, 2018 | 8,324 | -0.3% | Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗ |
| FY2017 | Apr 30, 2017 | 8,351 | +2.8% | Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗ |
| FY2016 | Apr 30, 2016 | 8,126 | – | Medtronic SEC 8K_EARNINGS — FY2017Q4 (filed 2017-05-25) ↗ |
Breakdown
What makes up non-gaap operating profit ($m)
- Non-GAAP Gross Margin (%)65.3% · FY2026
- Non-GAAP Operating Margin (%)24.4% · FY2026
- Non-GAAP R&D Expense ($M)2,872 · FY2026
- Non-GAAP R&D Expense (% of Revenue)7.9% · FY2026
- Non-GAAP SG&A Expense ($M)11,605 · FY2026
- Non-GAAP SG&A Expense (% of Revenue)31.9% · FY2026
- Non-GAAP Net Income Attributable to Medtronic ($M)7,120 · FY2026
- Non-GAAP Diluted EPS ($)5.53 · FY2026
- Non-GAAP Effective Tax Rate (%)17.3% · FY2026
- Non-GAAP Free Cash Flow ($M)5,426 · FY2026
Cite this data
StockData. (2026). Medtronic Non-GAAP Operating Profit ($M) ($M), annual FY2016–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ng-op-profit
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.